The immune responses to bacterial antigens encountered in vivo at mucosal surfaces
- 28 May 2000
- journal article
- review article
- Published by The Royal Society in Philosophical Transactions Of The Royal Society B-Biological Sciences
- Vol. 355 (1397) , 705-712
- https://doi.org/10.1098/rstb.2000.0610
Abstract
Mammals have evolved a sophisticated immune system for handling antigens encountered at their mucosal surfaces. The way in which mucosally delivered antigens are handled influences our ability to design effective mucosal vaccines. Live attenuated derivatives of pathogens are one route towards the development of mucosal vaccines. However, some molecules, described as mucosal immunogens, are inherently immunogenic at mucosal surfaces. Studies on mucosal immunogens may facilitate the identification of common characteristics that contribute to mucosal immunogenicity and aid the development of novel, non–living mucosal vaccines and immunostimulators.Keywords
This publication has 36 references indexed in Scilit:
- Effect of Small Bowel Bacterial Overgrowth on the Immunogenicity of Single‐Dose Live Oral Cholera Vaccine CVD 103‐HgRThe Journal of Infectious Diseases, 1999
- Oral tolerance in diseaseGut, 1999
- Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia.Journal of Clinical Investigation, 1998
- Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatmentVaccine, 1995
- Oral Vaccine Models: Multiple Delivery Systems Employing Tetanus ToxoidaAnnals of the New York Academy of Sciences, 1994
- Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD l03-HgRThe Journal of Infectious Diseases, 1992
- Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral Cholera Vaccine in Soldiers and Civilians in ThailandThe Journal of Infectious Diseases, 1992
- Enteropathogenic Escherichia coli and life threatening chronic diarrhoea.Gut, 1991
- Novel nonreplicating antigen delivery systemsCurrent Opinion in Infectious Diseases, 1990
- Shigella VaccinesClinical Infectious Diseases, 1989